Sandbox: malabsorption: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
Line 7: | Line 7: | ||
{| style="border: 0px; font-size: 100%; margin: 3px;" align="center" | {| style="border: 0px; font-size: 100%; margin: 3px;" align="center" | ||
! rowspan="5" style="background:#4479BA; color: #FFFFFF;" align="center" |Cause | ! rowspan="5" style="background:#4479BA; color: #FFFFFF;" align="center" |Cause | ||
| colspan=" | | colspan="10" style="background:#4479BA; color: #FFFFFF;" align="center" |'''Clinical manifestation''' | ||
! colspan="9" rowspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" |'''Lab findings''' | ! colspan="9" rowspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" |'''Lab findings''' | ||
! rowspan="5" style="background:#4479BA; color: #FFFFFF;" align="center" |Extra intestinal findings | ! rowspan="5" style="background:#4479BA; color: #FFFFFF;" align="center" |Extra intestinal findings | ||
Line 13: | Line 13: | ||
! rowspan="5" style="background:#4479BA; color: #FFFFFF;" align="center" |Gold standard diagnosis | ! rowspan="5" style="background:#4479BA; color: #FFFFFF;" align="center" |Gold standard diagnosis | ||
|- | |- | ||
! colspan=" | ! colspan="9" style="background:#4479BA; color: #FFFFFF;" align="center" |Symptoms | ||
! rowspan="4" style="background:#4479BA; color: #FFFFFF;" align="center" |GI signs | ! rowspan="4" style="background:#4479BA; color: #FFFFFF;" align="center" |GI signs | ||
|- | |- | ||
Line 20: | Line 20: | ||
! rowspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" |Fever | ! rowspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" |Fever | ||
! rowspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" |Abdominal pain | ! rowspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" |Abdominal pain | ||
! rowspan="3" |Vomiting | |||
! rowspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" |Weight loss | ! rowspan="3" style="background:#4479BA; color: #FFFFFF;" align="center" |Weight loss | ||
! | ! | ||
Line 49: | Line 50: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | ± | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | ± | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
Line 88: | Line 90: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
Line 126: | Line 129: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
Line 159: | Line 163: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
Line 192: | Line 197: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
Line 233: | Line 239: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |± | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |± | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
Line 263: | Line 270: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="Left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="Left" | | ||
Line 303: | Line 311: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="Left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="Left" | | ||
Line 332: | Line 341: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
Line 364: | Line 374: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
Line 392: | Line 403: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
Line 426: | Line 438: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
Line 464: | Line 477: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |± | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |± | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
Line 501: | Line 515: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
Line 535: | Line 550: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" |± | | style="padding: 5px 5px; background: #F5F5F5;" align="center" |± | ||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="left" | | | style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
Line 562: | Line 578: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 596: | Line 613: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 634: | Line 652: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 672: | Line 691: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 709: | Line 729: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 741: | Line 762: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | - | ||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | + | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 774: | Line 796: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 797: | Line 820: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 820: | Line 844: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 843: | Line 868: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 866: | Line 892: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 889: | Line 916: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 912: | Line 940: | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| | |||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
| style="padding: 5px 5px; background: #F5F5F5;" align="center" | | | style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 935: | Line 964: | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
Line 967: | Line 997: | ||
|- | |- | ||
! | ! | ||
| colspan=" | | colspan="10" |'''Clinical manifestation''' | ||
! colspan="9" rowspan="3" |'''Lab findings''' | ! colspan="9" rowspan="3" |'''Lab findings''' | ||
! rowspan="5" |Extra intestinal findings | ! rowspan="5" |Extra intestinal findings | ||
Line 974: | Line 1,004: | ||
|- | |- | ||
! style="background:#DCDCDC;" align="center" | | ! style="background:#DCDCDC;" align="center" | | ||
! colspan=" | ! colspan="9" style="padding: 5px 5px; background: #F5F5F5;" align="center" |Symptoms | ||
! rowspan="4" style="padding: 5px 5px; background: #F5F5F5;" align="left" |GI signs | ! rowspan="4" style="padding: 5px 5px; background: #F5F5F5;" align="left" |GI signs | ||
|- | |- | ||
Line 982: | Line 1,012: | ||
! rowspan="3" style="padding: 5px 5px; background: #F5F5F5;" align="center" |Fever | ! rowspan="3" style="padding: 5px 5px; background: #F5F5F5;" align="center" |Fever | ||
! rowspan="3" style="padding: 5px 5px; background: #F5F5F5;" align="center" |Abdominal pain | ! rowspan="3" style="padding: 5px 5px; background: #F5F5F5;" align="center" |Abdominal pain | ||
! | |||
! rowspan="3" style="padding: 5px 5px; background: #F5F5F5;" align="center" |Weight loss | ! rowspan="3" style="padding: 5px 5px; background: #F5F5F5;" align="center" |Weight loss | ||
|- | |- | ||
! style="background:#DCDCDC;" align="center" | | ! style="background:#DCDCDC;" align="center" | | ||
! | |||
! colspan="5" style="padding: 5px 5px; background: #F5F5F5;" align="center" |Stool exam | ! colspan="5" style="padding: 5px 5px; background: #F5F5F5;" align="center" |Stool exam | ||
| colspan="3" style="padding: 5px 5px; background: #F5F5F5;" align="center" |'''CBC''' | | colspan="3" style="padding: 5px 5px; background: #F5F5F5;" align="center" |'''CBC''' | ||
Line 995: | Line 1,027: | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Bloody | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Bloody | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Fatty | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |Fatty | ||
! | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |WBC | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |WBC | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |RBC | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |RBC | ||
Line 1,012: | Line 1,045: | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
Line 1,041: | Line 1,075: | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
Line 1,070: | Line 1,105: | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
Line 1,099: | Line 1,135: | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" | | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
Line 1,128: | Line 1,165: | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+/- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
Line 1,160: | Line 1,198: | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |+ | ||
! | |||
! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ! style="padding: 5px 5px; background: #F5F5F5;" align="center" |- | ||
! style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ! style="padding: 5px 5px; background: #F5F5F5;" align="left" | | ||
Line 1,192: | Line 1,231: | ||
! | ! | ||
!+ | !+ | ||
! | |||
!- | !- | ||
! | ! | ||
Line 1,215: | Line 1,255: | ||
!- | !- | ||
!+ | !+ | ||
! | |||
!+/- | !+/- | ||
! | ! |
Revision as of 22:43, 7 December 2017
Diarrhea
Abbreviations: GI: Gastrointestinal; WBC: White blood cells; Plt: Platelets, Hgb: Hemoglobin, IgE: Immunoglobulin E, IgA: Immunoglobulin A
Cause | Clinical manifestation | Lab findings | Extra intestinal findings | Cause/Pathogenesis | Gold standard diagnosis | |||||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Symptoms | GI signs | |||||||||||||||||||||
Duration | Diarrhea | Fever | Abdominal pain | Vomiting | Weight loss | |||||||||||||||||
Stool exam | CBC | Other lab findings | ||||||||||||||||||||
Acute | Chronic | Watery | Bloody | Fatty | WBC | RBC | Ova/Parasite | Osmotic gap | Other | WBC | Hgb | Plt | ||||||||||
Whipple's disease | - | + | + | - | + | ± | + | + | - | - | - | ↑ | ↓ | ↓ | ↓/↑ |
| ||||||
Celiac disease | - | + | ± | - | ± | - | + | + | ↑ | - | ↓ | - |
|
|
|
|||||||
Tropical sprue | + | + | + | - | + | + | + | + |
|
↑ | - | ↓ | - |
|
| |||||||
Crohns disease | - | + | + | + | + | + | + | + | - | ↑ | ↓ | ↑ |
|
|
|
| ||||||
Ulcerative colitis | - | + | + | + | + | + | + | + | - | ↑ | ↓ | ↑ |
|
|
| |||||||
Cystic fibrosis | - | + | - | - | + | ± | + | + | ↑ | - | ↓ | - |
|
|
| |||||||
VIPoma | + | + | + | - | + | - | + | + |
|
↓ | - | - | - |
|
|
| ||||||
Zollinger-Ellison syndrome | - | + | + | - | + | - | + | + | ↓ | - | ↓ | - |
|
| ||||||||
Eosinophilic gastroenteritis | - | + | + | - | + | - | + | + | ↑ | - | - |
|
|
|
| |||||||
Primary bile acid malabsorption | - | + | + | - | + | - | + | + | ↑ | - | ↓ | - |
|
|
| |||||||
Abetalipoproteinemia | - | + | + | - | + | - | + | + | - | - | - |
|
|
|
| |||||||
Microscopic colitis | - | + | + | + | - | - | + | + | - | - | ↓ | - |
|
|
|
| ||||||
Hyperthyroidism | - | + | + | - | - | ± | + | + | - | - | - |
|
||||||||||
Lactose intolerance | + | + | + | - | - | - | + | - | ↑ | - | - | - |
|
|
| |||||||
Irritable bowel syndrome | - | + | ± | - | ± | - | ± | - |
|
- | - | - | - |
| ||||||||
Chronic pancreatitis | - | + | + | - | + | - | + | + | ↑ | - | - | - |
|
|
||||||||
Cirrhosis | - | + | + | - | + | + | + | + |
|
↑ | ↓ | ↓ | ↓ |
|
|
|
| |||||
Short bowel syndrome | + | + | + | - | + | - | - | + |
|
↑ | - | ↓ | ↑ |
|
|
|
||||||
Small bowel bacterial overgrowth | - | + | + | - | + | - | + | + | - | ↓ | - |
|
|
| ||||||||
X-linked agammaglobulinemia | - | + | + | - | + | + | + | + |
|
- | ↓ | ↓ | - |
|
|
|
| |||||
Intestinal lymphangiectasia | - | + | - | - | + | - | - | + |
|
- | ↓ | - | - |
|
|
|
Intestinal biopsy | |||||
Amyloidosis | + | |||||||||||||||||||||
Mastocytosis | ||||||||||||||||||||||
Drug induced enteritis | ||||||||||||||||||||||
Giardiasis | + | |||||||||||||||||||||
Strongyloidiasis | ||||||||||||||||||||||
Tuberculosis | ||||||||||||||||||||||
Chronic laxative abuse | ||||||||||||||||||||||
Pseudomembranous colitis | + | - | + | +/- | - | + | + | +/- |
|
|
↑ | ↓ | ↓ |
|
|
| ||||||
Clinical manifestation | Lab findings | Extra intestinal findings | Cause/Pathogenesis | Gold standard diagnosis | ||||||||||||||||||
Symptoms | GI signs | |||||||||||||||||||||
Duration | Diarrhea | Fever | Abdominal pain | Weight loss | ||||||||||||||||||
Stool exam | CBC | Other lab findings | ||||||||||||||||||||
Acute | Chronic | Watery | Bloody | Fatty | WBC | RBC | Ova/Parasite | Osmotic gap | Other | WBC | Hgb | Plt | ||||||||||
CMV collitis | + | + | +/- | + | - |
|
+/- | + | - | - |
|
↓ | - | - |
|
|
|
| ||||
Macrobacterium Aviom Complex | + | + | +/- | + | - |
|
+/- | + | - | - |
|
↓ | - | - |
|
|
|
| ||||
Colon cancer | + | + | + | + |
|
- | + | - | - |
|
- | ↑/↓ | - |
|
|
|
| |||||
Intestinal metastasis | + | + | + | + |
|
- | + | - | - |
|
↑/↓ | ↑/↓ | ↑/↓ |
|
|
|
| |||||
Infectious Diarrhea | + | + | - | + | +/- |
|
+ | + | - | - |
|
↑ | - | - |
|
|
|
| ||||
Infectious Diarrhea | + | + | + | + | - |
|
+ | + | - | - |
|
↑ | - | - |
|
|
|
| ||||
Isosporiasis | + | + | + | - | + | + | - | - | ↑ | - | ||||||||||||
Parasitic Diarrhea | + | + | + | - | + | +/- | + | + | + | - | ↑ | - | - | Amebiasis
Intestinal Schistosomiasis Balantidiasis Trichuriasis |